We are excited to announce two poster presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting, taking place November 5-9, 2025, in National Harbor, MD.

Presentation Details

Title: Design of a Next Generation Tumor Targeted Masked IL-12Fc for Enhanced Tolerability and Localized Anti-Tumor Activity
Abstract Number: 853
Date: November 7
Category: Immune-Stimulants and Immune Modulators

Title: TriTCE Co-stim: A differentiated T cell engager platform with conditional cis CD28 co-stimulation is transferable to diverse targeting strategies
Abstract Number: 1196
Date: November 8
Category: Novel Single-Agent Immunotherapies

The posters will be available to conference attendees as virtual e-posters on the virtual meeting platform on November 4, 2025, at 9 am Eastern Time. The poster will also be available on the Publications page of our website.